Keyphrases
Additional Treatment
9%
Autophagy
36%
Autophagy Inhibition
100%
Cell Proliferation
9%
Cellular Systems
9%
Chloroquine
18%
EGFRvIII
100%
Enhanced Tolerance
9%
Glioblastoma
81%
Hypoxia
9%
Hypoxic Tumor Cells
9%
Macroautophagy
9%
Metabolic Demand
9%
Metabolic Dependencies
100%
Metabolic Stress
18%
Metabolic Therapy
100%
Patient-derived Tumor Xenograft
9%
Patient-derived Tumors
9%
Poor Prognosis
9%
Radioresistant
9%
Retrospective Analysis
9%
Starvation
9%
Stress Conditions
9%
Survival Benefit
9%
Therapeutic Potential
18%
Therapeutic Vulnerabilities
100%
Therapy Resistance
18%
Treatment Strategy
9%
Tumor
18%
Tumor Growth
18%
Tumor Hypoxia
9%
Worse Prognosis
9%
INIS
cell proliferation
11%
demand
11%
glioblastomas
100%
growth
22%
hypoxia
22%
inhibition
100%
patients
88%
phenotype
11%
proliferation
11%
radioresistant
11%
starvation
11%
therapy
22%
tolerance
22%
tumor cells
11%
tumors
77%
vulnerability
100%
Medicine and Dentistry
Autophagy
100%
Cell Proliferation
11%
Chloroquine
22%
Glioblastoma
100%
Hypoxia
11%
Macroautophagy
11%
Metabolic Stress
22%
Neoplasm
33%
Therapy Resistance
22%
Tumor Cell
11%
Tumor Hypoxia
11%
Tumor Progression
22%
Tumor Xenograft
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chloroquine
22%
Glioblastoma
100%
Hypoxia
22%
Metabolic Stress
22%
Neoplasm
66%
Therapy Resistance
22%
Tumor Growth
22%
Biochemistry, Genetics and Molecular Biology
Autophagy
100%
Cell Proliferation
14%
Macroautophagy
14%
Tumor Hypoxia
14%
Tumor Progression
28%
Neuroscience
Autophagy
100%
Cell Proliferation
14%
Chloroquine
28%
Macroautophagy
14%